Yueming Qian, MD, PhD, Director of Process Development at Pre-Pivotal Drug Substance Technologies of Amgen Inc. With a career that began in studying drug targets, Dr. Qian has since specialized in biologics development and production. His areas of expertise include cell line development and cell culture process development. He also served as a liaison between discovery and process development, coordinating program advancement from molecule selection to modality-appropriate cell line development.
Amgen (United States)
Thousand Oaks, California, USA
Process Development